SPRINGER TIMOTHY A 4
4 · Cartesian Therapeutics, Inc. · Filed Apr 11, 2025
Insider Transaction Report
Form 4
SPRINGER TIMOTHY A
Director10% Owner
Transactions
- Purchase
Common Stock
2025-04-10$10.43/sh+7,966$83,121→ 8,636,664 total - Purchase
Common Stock
2025-04-11$10.77/sh+6,412$69,074→ 8,643,685 total - Purchase
Common Stock
2025-04-09$9.95/sh+31$308→ 8,628,698 total - Purchase
Common Stock
2025-04-09$9.95/sh+178$1,771→ 571,580 total(indirect: See Footnote) - Purchase
Common Stock
2025-04-10$10.43/sh+45,144$471,055→ 616,724 total(indirect: See Footnote) - Purchase
Common Stock
2025-04-09$9.43/sh+7,342$69,209→ 8,628,667 total - Purchase
Common Stock
2025-04-09$9.43/sh+41,604$392,176→ 571,402 total(indirect: See Footnote) - Purchase
Common Stock
2025-04-10$10.92/sh+609$6,652→ 8,637,273 total - Purchase
Common Stock
2025-04-10$10.92/sh+3,451$37,696→ 620,175 total(indirect: See Footnote) - Purchase
Common Stock
2025-04-11$10.77/sh+36,338$391,455→ 656,513 total(indirect: See Footnote)
Holdings
- 330,695(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $8.95 to $9.91. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $9.95 to $9.97. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F3]Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
- [F4]The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $9.918 to $10.7461. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F5]The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $10.395 to $11.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.